FDA Inspection
Yabao Pharmaceutical Co., Ltd. BeijingFDA Inspection 1168163 - Yabao Pharmaceutical Co., Ltd. Beijing - April 20, 2022
Record Details
This FDA Inspection record concerns Yabao Pharmaceutical Co., Ltd. Beijing, with an inspection on April 20, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 20, 2022
- Product Type
- Drugs
View Company Profile
ID · f0d187ef-2f77-43c0-85b9-71d81ce83941
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1168163
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Yabao Pharmaceutical Co., Ltd. Beijing
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | Not classified | Office of Inspections and Investigations | |
| April 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Yabao Pharmaceutical Co., Ltd. Beijing
- FDA Inspection 1309898 - 2026-03-06
- FDA Inspection 923752 - 2015-04-03
- FDA Inspection 849070 - 2013-08-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.